Months after U.S. approval, the twice-yearly HIV prevention injection lenacapavir is rolling out in African countries hit hardest by the epidemic. With early doses delivered to Zambia and Eswatini, the project marks a big step toward wider, equitable access.
Long-Acting HIV prevention drug lenacapavir lands in Africa at last
NPR
